Naga P Chalasani (N Chalasani, Naga Chalasani)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 52

Top Topics

Top Venues

Alimentary pharmacology & therapeutics

Hepatology (Baltimore, Md.)

Hepatology communications

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Samer Gawrieh, Mark S Sulkowski, Naga P Chalasani, Rohit Loomba
Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States-Authors' reply. Alimentary pharmacology & therapeutics 59 (6) (2024)
Naim Alkhouri, Anne-Cécile V Bayne, Naga P Chalasani
Editorial: Decoding the enigma-Navigating complexity in MASLD management. Authors' reply. Alimentary pharmacology & therapeutics 60 (6) (2024)
Samer Gawrieh, Mark S Sulkowski, Naga P Chalasani, Rohit Loomba
Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States-Authors' reply. Alimentary pharmacology & therapeutics 59 (6) (2024)
Harish Gopalakrishna, Naga P Chalasani
Drug-induced liver injury due to first-line antituberculosis medications in India: A major hindrance to achieve the goal of tuberculosis elimination. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology (2024)
Naga P Chalasani, Eduardo Vilar-Gomez, Stephen Caldwell, Katherine P Yates, Anna Mae Diehl, Brent A Neuschwander-Tetri, Srinivasan Dasarathy, Kris V Kowdley, Norah A Terrault, Laura A Wilson, James Tonascia, Arun J Sanyal
PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease. Hepatology (Baltimore, Md.) (2024)
Naim Alkhouri, Anne-Cécile V Bayne, Naga P Chalasani
Editorial: Decoding the enigma-Navigating complexity in MASLD management. Authors' reply. Alimentary pharmacology & therapeutics (2024)
Naim Alkhouri, Deanna McCarthy, Anne-Cécile V Bayne, Traci Blonquist, Karin Yurko-Mauro, Raj K Vuppalanchi, Eric Lawitz, Naga P Chalasani
The effect of vitamin E and docosahexaenoic acid ethyl ester on Metabolic Dysfunction-Associated steatotic Liver Disease (MASLD)-A randomised, double-blind, placebo-controlled, parallel-group clinical trial (PUVENAFLD). Alimentary pharmacology & therapeutics 60 (5) (2024)
Daniela S Allende, Oscar Cummings, Alice L Sternberg, Cynthia A Behling, Danielle Carpenter, Ryan M Gill, Cynthia D Guy, Matthew M Yeh, Samer Gawrieh, Richard K Sterling, Susanna Naggie, Rohit Loomba, Jennifer C Price, Mary McLaughlin, Colleen Hadigan, Holly Crandall, Patricia Belt, Laura Wilson, Naga P Chalasani, David E Kleiner, null null
MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls. Alimentary pharmacology & therapeutics (2024)
Samer Gawrieh, Mark S Sulkowski, Naga P Chalasani, Rohit Loomba
Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States-Authors' reply. Alimentary pharmacology & therapeutics 59 (6) (2024)
Samer Gawrieh, Mark S Sulkowski, Naga P Chalasani, Rohit Loomba
Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States-Authors' reply. Alimentary pharmacology & therapeutics 59 (6) (2024)
Naim Alkhouri, Deanna McCarthy, Anne-Cécile V Bayne, Traci Blonquist, Karin Yurko-Mauro, Raj K Vuppalanchi, Eric Lawitz, Naga P Chalasani
The effect of vitamin E and docosahexaenoic acid ethyl ester on Metabolic Dysfunction-Associated steatotic Liver Disease (MASLD)-A randomised, double-blind, placebo-controlled, parallel-group clinical trial (PUVENAFLD). Alimentary pharmacology & therapeutics (2024)
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, Jordan E Lake, Laura A Wilson, Jennifer C Price, Susanna Naggie, Richard K Sterling, Sonya Heath, Kathleen E Corey, Edward R Cachay, Veeral Ajmera, James Tonascia, Mark S Sulkowski, Naga P Chalasani, Stephen Caldwell
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Alimentary pharmacology & therapeutics 59 (5) (2023)
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, Jordan E Lake, Laura A Wilson, Jennifer C Price, Susanna Naggie, Richard K Sterling, Sonya Heath, Kathleen E Corey, Edward R Cachay, Veeral Ajmera, James Tonascia, Mark S Sulkowski, Naga P Chalasani, Stephen Caldwell
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Alimentary pharmacology & therapeutics 59 (5) (2023)
Nicholas R Powell, Tiebing Liang, Joseph Ipe, Sha Cao, Todd C Skaar, Zeruesenay Desta, Hui-Rong Qian, Philip J Ebert, Yu Chen, Melissa K Thomas, Naga P Chalasani
Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease. Nature communications 14 (1) (2023)
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, Jordan E Lake, Laura A Wilson, Jennifer C Price, Susanna Naggie, Richard K Sterling, Sonya Heath, Kathleen E Corey, Edward R Cachay, Veeral Ajmera, James Tonascia, Mark S Sulkowski, Naga P Chalasani, Stephen Caldwell
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Alimentary pharmacology & therapeutics (2023)
Mazen Noureddin, Zachary Goodman, Dean Tai, Elaine L K Chng, Yayun Ren, Pol Boudes, Harold Shlevin, Guadalupe Garcia-Tsao, Stephen A Harrison, Naga P Chalasani
Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis. Alimentary pharmacology & therapeutics (2023)
Mazen Noureddin, Zachary Goodman, Dean Tai, Elaine L K Chng, Yayun Ren, Pol Boudes, Harold Shlevin, Guadalupe Garcia-Tsao, Stephen A Harrison, Naga P Chalasani
Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis. Alimentary pharmacology & therapeutics 57 (4) (2023)
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, Jordan E Lake, Laura A Wilson, Jennifer C Price, Susanna Naggie, Richard K Sterling, Sonya Heath, Kathleen E Corey, Edward R Cachay, Veeral Ajmera, James Tonascia, Mark S Sulkowski, Naga P Chalasani, Stephen Caldwell
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Alimentary pharmacology & therapeutics 59 (5) (2023)
Nicholas R Powell, Tiebing Liang, Joseph Ipe, Sha Cao, Todd C Skaar, Zeruesenay Desta, Hui-Rong Qian, Philip J Ebert, Yu Chen, Melissa K Thomas, Naga P Chalasani
Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease. Nature communications 14 (1) (2023)
Mazen Noureddin, Zachary Goodman, Dean Tai, Elaine L K Chng, Yayun Ren, Pol Boudes, Harold Shlevin, Guadalupe Garcia-Tsao, Stephen A Harrison, Naga P Chalasani
Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis. Alimentary pharmacology & therapeutics 57 (4) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) (2023)
Nicholas R Powell, Tiebing Liang, Joseph Ipe, Sha Cao, Todd C Skaar, Zeruesenay Desta, Hui-Rong Qian, Philip J Ebert, Yu Chen, Melissa K Thomas, Naga P Chalasani
Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease. Nature communications 14 (1) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) 77 (4) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) 77 (4) (2023)
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, Jordan E Lake, Laura A Wilson, Jennifer C Price, Susanna Naggie, Richard K Sterling, Sonya Heath, Kathleen E Corey, Edward R Cachay, Veeral Ajmera, James Tonascia, Mark S Sulkowski, Naga P Chalasani, Stephen Caldwell
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Alimentary pharmacology & therapeutics 59 (5) (2023)
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, Jordan E Lake, Laura A Wilson, Jennifer C Price, Susanna Naggie, Richard K Sterling, Sonya Heath, Kathleen E Corey, Edward R Cachay, Veeral Ajmera, James Tonascia, Mark S Sulkowski, Naga P Chalasani, Stephen Caldwell
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Alimentary pharmacology & therapeutics 59 (5) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) 77 (4) (2023)
Melissa Palmer, David E Kleiner, Zachary Goodman, Elizabeth Brunt, Mark I Avigan, Arie Regev, Paul H Hayashi, James H Lewis, Ruby Mehta, Stephen A Harrison, Massimo Siciliano, Charles A McWherter, Raj K Vuppalanchi, Cynthia Behling, Veronica Miller, Naga P Chalasani, Arun J Sanyal
Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver Forum. Alimentary pharmacology & therapeutics (2023)
Yan Wang, Matthew Hamang, Alexander Culver, Huaizhou Jiang, Jennifer Yanum, Veronica Garcia, Joonyong Lee, Emily White, Praveen Kusumanchi, Naga P Chalasani, Suthat Liangpunsakul, Benjamin C Yaden, Guoli Dai
Activin B promotes the initiation and progression of liver fibrosis. Hepatology communications 6 (10) (2022)
Eduardo Vilar-Gomez, Carlos Jose Pirola, Silvia Sookoian, Laura A Wilson, Tiebing Liang, Naga P Chalasani
PNPLA3 rs738409 and risk of fibrosis in NAFLD: Exploring mediation pathways through intermediate histological features. Hepatology (Baltimore, Md.) 76 (5) (2022)
Kawthar A Mohamed, Marwan S Ghabril, Archita Desai, Eric Orman, Kavish R Patidar, John Holden, Susan Rawl, Naga P Chalasani, Chandrashekhar A Kubal, Lauren D Nephew
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 28 (9) (2022)
Danielle Brandman, Marie Boyle, McPherson Stuart, Mark L Van Natta, Arun J Sanyal, Kris Kowdley, Brent Neuschwander-Tetri, Naga P Chalasani, Manal F Abdelmalek, Norah A Terrault, Art McCullough, Ricki Bettencourt, Cyrielle Caussy, David E Kleiner, Cynthia Behling, James Tonascia, Quentin Mark Anstee, Stephen Caldwell, null null
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD). Alimentary pharmacology & therapeutics 55 (11) (2022)
Mark Dhinesh Muthiah, Ekaterina Smirnova, Puneet Puri, Naga P Chalasani, Vijay H Shah, Calvin Kiani, Stephanie Taylor, Faridoddin Mirshahi, Arun J Sanyal
Development of Alcohol-Associated Hepatitis Is Associated With Specific Changes in Gut-Modified Bile Acids. Hepatology communications 6 (5) (2022)
Jiayi Ma, Naga P Chalasani, Linus Schwantes-An, Einar Stefan Björnsson
Review: the safety of anticoagulants and antiplatelet agents in patients with cirrhosis. Alimentary pharmacology & therapeutics (2022)
Samer Gawrieh, Laura A Wilson, Katherine P Yates, Oscar W Cummings, Eduardo Vilar-Gomez, Veeral H Ajmera, Kris V Kowdley, William M Rosenberg, James Tonascia, Naga P Chalasani
Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial. Hepatology communications 5 (5) (2021)
Marwan S Ghabril, Jiayi Ma, Kavish R Patidar, Lauren D Nephew, Archita P Desai, Eric S Orman, Raj K Vuppalanchi, Chandrashekhar A Kubal, Naga P Chalasani
Eight-Fold Increase in Dietary Supplement-Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2021)
Samer Gawrieh, Mazen Noureddin, Nicole Loo, Rizwana Mohseni, Vivek Awasty, Kenneth Cusi, Kris V Kowdley, Michelle Lai, Eugene Schiff, Deven Parmar, Pankaj Patel, Naga P Chalasani
Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial. Hepatology (Baltimore, Md.) 74 (4) (2021)
Eduardo Vilar-Gomez, Lauren D Nephew, Raj K Vuppalanchi, Samer Gawrieh, Andrea Mladenovic, Francis Pike, Niharika Samala, Naga P Chalasani
High quality diet, physical activity and college education are associated with low risk of NAFLD among the U.S. population. Hepatology (Baltimore, Md.) (2021)
Zhihong Yang, Ting Zhang, Praveen Kusumanchi, Qing Tang, Zhaoli Sun, Svetlana Radaeva, Brandon Peiffer, Vijay H Shah, Patrick Kamath, Greg J Gores, Arun Sanyal, Naga P Chalasani, Yanchao Jiang, Nazmul Huda, Jing Ma, Suthat Liangpunsakul
Transcriptomic Analysis Reveals the MicroRNAs Responsible for Liver Regeneration Associated With Mortality in Alcohol-Associated Hepatitis. Hepatology (Baltimore, Md.) 74 (5) (2021)
Kunpeng Hu, Maria C Perez-Matos, Josepmaria Argemi, Eduardo Vilar-Gomez, Irina Shalaurova, Esther Bullitt, Lee Landeen, Go Sugahara, Huiyan Deng, Karan Mathur, Stephanie Tran, Huimei Cai, Hanchang He, Yusuf Yalcin, Joana Vieira Barbosa, Meritxell Ventura-Cots, Katherine Marx, Aniket P Gad, Sebastian Niezen, Sofia Izunza Barba, Lay-Hong Ang, Yury V Popov, Zachary Fricker, Michelle Lai, Michael Curry, Nezam Afdhal, Gyongyi Szabo, Kenneth J Mukamal, Arun J Sanyal, James D Otvos, Raza Malik, Takeshi Saito, Margery A Connelly, Naga P Chalasani, Ramon A Bataller, Zhenghui Gordon Jiang
Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitis. Hepatology (Baltimore, Md.) (2021)
Luis Calzadilla Bertot, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Manuel Romero, Rocio Aller-de la Fuente, Grace Lai-Hung Wong, Marlen Ivón Castellanos-Fernández, Mohammed Eslam, Archita P Desai, Gary P Jeffrey, Jacob George, Naga P Chalasani, Leon A Adams
ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis. Hepatology (Baltimore, Md.) 73 (6) (2021)
Sydney F Pomenti, Cassandra Gandle, Hamzah Abu Sbeih, Meaghan Phipps, Alexandra Livanos, Averill Guo, Jonathan Yeh, Heather Burney, Hao Liu, Lara Dakhoul, Carla Kettler, Samer Gawrieh, Andrew deLemos, Andrew Scanga, Naga P Chalasani, Ethan Miller, Julia Wattacheril
Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort. Hepatology communications 4 (11) (2020)
Michael B Zemel, Orville Kolterman, Mary Rinella, Raj K Vuppalanchi, Omar Flores, A Sidney Barritt, Mohammad Bilal Siddiqui, Naga P Chalasani
Randomized Controlled Trial of a Leucine-Metformin-Sildenafil Combination (NS-0200) on Weight and Metabolic Parameters. Obesity (Silver Spring, Md.) 27 (1) (2020)
Craig Steven Lammert, Chengsong Zhu, Yun Lian, Indu Raman, George Eckert, Quan-Zhen Li, Naga P Chalasani
Exploratory Study of Autoantibody Profiling in Drug-Induced Liver Injury with an Autoimmune Phenotype. Hepatology communications 4 (11) (2020)
Shaminie Athinarayanan, Yang-Yi Fan, Xiaokun Wang, Evelyn Callaway, Defeng Cai, Naga P Chalasani, Robert S Chapkin, Wanqing Liu
Fatty Acid Desaturase 1 Influences Hepatic Lipid Homeostasis by Modulating the PPARα-FGF21 Axis. Hepatology communications 5 (3) (2020)
Kathleen E Corey, Laura A Wilson, Akif Altinbas, Katherine P Yates, David E Kleiner, Raymond T Chung, Ronald M Krauss, Naga P Chalasani, null null
Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial. Alimentary pharmacology & therapeutics 49 (9) (2019)
Andrew A Stolz, Victor Navarro, Paul H Hayashi, Robert J Fontana, Huiman X Barnhart, Jiezhun Gu, Naga P Chalasani, Maricruz M Vega, Herbert L Bonkovsky, Leonard B Seeff, Jose Serrano, Bharathi Avula, Ikhlas A Khan, Elizabeth T Cirulli, David E Kleiner, Jay H Hoofnagle, null null
Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors. Alimentary pharmacology & therapeutics 49 (9) (2019)
Samer Gawrieh, Lara Dakhoul, Ethan Miller, Andrew Scanga, Andrew deLemos, Carla Kettler, Heather Burney, Hao Liu, Hamzah Abu-Sbeih, Naga P Chalasani, Julia Wattacheril
Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study. Alimentary pharmacology & therapeutics 50 (7) (2019)
Megan Comerford, Rachel Fogel, James Robert Bailey, Prianka Chilukuri, Naga P Chalasani, Craig Steven Lammert
Leveraging Social Networking Sites for an Autoimmune Hepatitis Genetic Repository: Pilot Study to Evaluate Feasibility. Journal of medical Internet research 20 (1) (2018)
Naga P Chalasani, R Vuppalanchi, M Rinella, M S Middleton, M S Siddiqui, A S Barritt, O Kolterman, O Flores, C Alonso, M Iruarrizaga-Lejarreta, R Gil-Redondo, C B Sirlin, Michael B Zemel
Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 47 (12) (2018)
Alexander J Kovalic, Sanjaya K Satapathy, Naga P Chalasani
Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis. Hepatology international 12 (2) (2018)
Rachel Fogel, Megan Comerford, Prianka Chilukuri, Eric S Orman, Naga P Chalasani, Craig Steven Lammert
Extrahepatic Autoimmune Diseases are Prevalent in Autoimmune Hepatitis Patients and Their First-Degree Relatives: Survey Study. Interactive journal of medical research 7 (2) (2018)